Literature DB >> 4502530

Daunorubicin metabolism in acute myelocytic leukemia.

D H Huffman, N R Bachur.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4502530

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  A survey of the anthracycline derivatives in hematology.

Authors:  C Jacquillat; M Weil; M F Auclerc; J Maral; G Schaison; M Boiron; J Bernard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

2.  Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.

Authors:  D Londos-Gagliardi; R Baurain; J Robert; G Aubel-Sadron
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

3.  Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus.

Authors:  M Blumauerová; E Královcová; J Matĕjů; J Jizba; Z Vanĕk
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

Review 4.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

5.  Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.

Authors:  Federico Pea; Domenico Russo; Mariagrazia Michieli; Daniela Damiani; Renato Fanin; Angela Michelutti; Teresa Michelutti; Stefano Piccolrovazzi; Michele Baccarani; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

6.  Quantitative evaluation of intracellular uptake of daunorubicin in acute myeloid leukemia: a method analysis.

Authors:  E Kokenberg; P Sonneveld; K Nooter; K van der Steuyt; B Löwenberg
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Prognostic effect of gender on outcome of treatment for adults with acute myeloid leukaemia.

Authors:  Peter H Wiernik; Zhuoxin Sun; Larry D Cripe; Jacob M Rowe; Hugo F Fernandez; Selina M Luger; Hillard M Lazarus; Elisabeth M Paietta; Martin S Tallman; Mark R Litzow
Journal:  Br J Haematol       Date:  2021-06-17       Impact factor: 8.615

8.  Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.

Authors:  P Galettis; J Boutagy; D D Ma
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.